The Centers for Disease Control (CDC) has released a report indicating the percentage of all ED visits by adults in which an opioid was prescribed at discharge increased from 19.0 percent in 2006–2007 to 21.5 percent in 2010–2011, and decreased to 14.6 percent in 2016–2017, representing a 30.1 percent decrease from 2006–2007 to 2016–2017.
This finding is consistent with the trend in national opioid prescribing rates based on pharmacy data in which rates increased from 2006 through 2010, were constant from 2010–2012, and decreased from 2012–2015. A similar trend in the percentage of ED visits with opioids prescribed at discharge was observed for most of the patient characteristics examined in this report. The decreasing trend starting in 2010–2011 may be related to several factors: decreasing volume of prescription opioids; the hundreds of local, state, and federal programs that were implemented with the goal of changing prescribing practices; and prescription drug monitoring programs.
This report describes trends in opioid prescribing at emergency department (ED) discharge among adults from 2006–2007 through 2016–2017, by selected patient and hospital characteristics and the type of opioids prescribed. Methods—Data are from the 2006–2017 National Hospital Ambulatory Medical Care Survey.
The study population included all ED visits by patients aged 18 and over. The main outcome studied was opioids prescribed at ED discharge, defined using Cerner Multum’s third-level therapeutic category codes for narcotic analgesics (Code 60) and narcotic-analgesic combinations (Code 191).
The rate of decrease was highest among visits by younger adults aged 18–44 (from 25.5 percent in 2010–2011 to 15.3 percent in 2016–2017) and those living in medium or small metropolitan counties (24.3 percent in 2010–2011 to 14.5 percent in 2016–2017).
The percentage of visits with morphine-equivalent opioids prescribed increased from 2006–2007 (11.3 percent) through 2010–2011 (12.4 percent) and decreased from 2010–2011 through 2016–2017 (6.7 percent). The percentage of visits with stronger than morphine opioids prescribed similarly increased from 2006–2007 (3.8 percent) through 2010–2011 (5.5 percent) and decreased to 3.0 percent in 2016–2017.
In contrast, the percentage of visits with weaker than morphine opioids prescribed decreased from 4.0 percent in 2006–2007 through 3.6 percent in 2010–2011 and increased to 5.0 percent in 2016–2017. Among all opioids prescribed at discharge, the percentage with acetaminophen-hydrocodone prescribed decreased from 53.1 percent in 2012–2013 to 41.5 percent in 2016–2017, with a corresponding increase for both tramadol and acetaminophen-codeine. Top diagnoses associated with an opioid prescribed at discharge included dental pain, urolithiasis (stones in the kidney, bladder, or urinary tract), fracture injuries, back pain and extremity pain.
For all top diagnoses, the percentage of visits with an opioid prescribed decreased from 2010–2011 through 2016–2017, though the decrease was not statistically significant for urolithiasis.